collection
https://read.qxmd.com/read/38558263/montreal-cognitive-assessment-moca-xpresso-validation-of-a-digital-self-administered-cognitive-prescreening-tool
#1
JOURNAL ARTICLE
Sivan Klil-Drori, Katie C Bodenstein, Shuo Sun, Lara Kojok, Johanna Gruber, Youssef Ghantous, Jeffrey Cummings, Ziad Nasreddine
BACKGROUND: The need for cognitive testing is increasing with the aging population and the advent of new Alzheimer disease therapies. To respond to the increased demand, the XpressO was developed as a self-administered digital cognitive prescreening tool that will help distinguish between populations of subjective and objective cognitive impairment according to the Montreal Cognitive Assessment (MoCA). METHODS: This is a prospective validation study. XpressO is composed of tasks that assess memory and executive functions...
April 1, 2024: Journal of the American Geriatrics Society
https://read.qxmd.com/read/38558015/progress-in-pharmacologic-management-of-neuropsychiatric-syndromes-in-neurodegenerative-disorders-a-review
#2
JOURNAL ARTICLE
Jeffrey Cummings, Krista Lanctot, George Grossberg, Clive Ballard
IMPORTANCE: Neuropsychiatric syndromes (NPSs) are common in neurodegenerative disorders (NDDs); compromise the quality of life of patients and their care partners; and are associated with faster disease progression, earlier need for nursing home care, and poorer quality of life. Advances in translational pharmacology, clinical trial design and conduct, and understanding of the pathobiology of NDDs are bringing new therapies to clinical care. OBSERVATIONS: Consensus definitions have evolved for psychosis, agitation, apathy, depression, and disinhibition in NDDs...
April 1, 2024: JAMA Neurology
https://read.qxmd.com/read/38513620/neuropsychiatric-profiles-and-cerebral-amyloid-burden-in-adults-without-dementia
#3
JOURNAL ARTICLE
Eva Q Gontrum, Emily W Paolillo, Shannon Lee, Valentina Diaz, Alexander Ehrenberg, Rowan Saloner, Nidhi S Mundada, Renaud La Joie, Gil Rabinovici, Joel H Kramer, Kaitlin Casaletto
INTRODUCTION: We comprehensively evaluated how self- and informant-reported neuropsychiatric symptoms (NPS) differentially associated with cerebral amyloid-beta (Aβ) PET levels in older adults without dementia. METHODS: 221 participants (48% female, age=73.4y±8.4, CDR=0 [n=184] or 0.5 [n=37]) underwent an Aβ-PET scan (Florbetapir or PIB), comprehensive neuropsychological testing, and self-reported (Geriatric Depression Scale- 30 item), and informant-reported interview (Neuropsychiatric Inventory Questionnaire) of NPS...
March 21, 2024: Dementia and Geriatric Cognitive Disorders
https://read.qxmd.com/read/38593753/association-of-performance-on-multiple-cognitive-domains-with-sarcopenia-among-middle-aged-and-older-adults
#4
JOURNAL ARTICLE
Yafei Wu, Zongjie Wang, Ya Fang
INTRODUCTION: The relationship between cognitive function and subsequent sarcopenia remains unclear. Therefore, this study aimed to examine the associations of performance on multiple cognitive domains with sarcopenia in the middle-aged and older adults. METHODS: This longitudinal analysis (wave 2011-2013) included 2934 participants from the CHARLS study. Sarcopenia was defined by the Asian Sarcopenia Working Group 2019 criteria. Cognitive function was measured by the Chinese version of the Mini-Mental State Examination (MMSE)...
April 9, 2024: Dementia and Geriatric Cognitive Disorders
https://read.qxmd.com/read/38580328/proarrhythmic-major-adverse-cardiac-events-with-donepezil-a-systematic-review-with-meta-analysis
#5
REVIEW
Tina Nham, Michael Cristian Garcia, Kai La Jennifer Tsang, Jessyca Matos Silva, Tyler Schneider, Jiawen Deng, Simran Lohit, Lawrence Mbuagbaw, Anne Holbrook
BACKGROUND: Cholinesterase inhibitors (ChEIs) are regularly used in Alzheimer's disease. Of the three ChEIs approved for dementia, donepezil is among the most prescribed drugs in the United States with nearly 6 million prescriptions in 2020; however, it is classified as a "known risk" QT interval-prolonging medication (QTPmed). Given this claim is derived from observational data including single case reports, we aimed to evaluate high-quality literature on the frequency and nature of proarrhythmic major adverse cardiac events (MACE) associated with donepezil...
April 5, 2024: Journal of the American Geriatrics Society
https://read.qxmd.com/read/38131058/efficacy-and-safety-of-pharmacotherapy-in-chronic-insomnia-a-review-of-clinical-guidelines-and-case-reports
#6
REVIEW
Alejandro Del Rio Verduzco, Ahva Salari, Parna Haghparast
INTRODUCTION: Chronic insomnia affects 5% to 10% of the US population, increasing the demand for treatment options and the corresponding research to prove their validity.1 This review compares recommendations from 3 clinical guidelines and summarizes hypnotic medications, including their newly reported side effects not mentioned in the guidelines. In addition, we aim to provide an overview of what pharmacotherapies are available for prescribers and patients. METHODS: A literature search was conducted for articles published prior to January 10, 2022, and case reports and clinical studies were retrieved from PubMed and Google Scholar...
October 2023: Mental Health Clinician
https://read.qxmd.com/read/38490803/kdigo-2024-clinical-practice-guideline-for-the-evaluation-and-management-of-chronic-kidney-disease
#7
(no author information available yet)
No abstract text is available yet for this article.
April 2024: Kidney International
https://read.qxmd.com/read/38504389/current-understanding-of-nociplastic-pain
#8
JOURNAL ARTICLE
Yeong-Min Yoo, Kyung-Hoon Kim
Nociplastic pain by the "International Association for the Study of Pain" is defined as pain that arises from altered nociception despite no clear evidence of nociceptive or neuropathic pain. Augmented central nervous system pain and sensory processing with altered pain modulation are suggested to be the mechanism of nociplastic pain. Clinical criteria for possible nociplastic pain affecting somatic structures include chronic regional pain and evoked pain hypersensitivity including allodynia with after-sensation...
March 20, 2024: Korean Journal of Pain
https://read.qxmd.com/read/38507749/alzheimer-s-disease-managing-stages-of-dementia
#9
JOURNAL ARTICLE
Nathaniel A Chin, Debra Dinsmore, Tony Gonzales, Betsy Groves, Stephanie Houston, Dan Johnson, DeLois Johnson, Julia Napolitano, Allan Ropper, Stephen Salloway, Rob Sutherland, Lori Weiss, Karen Wheelock
New England Journal of Medicine, Volume 390, Issue 12, March 21/28, 2024.
March 21, 2024: New England Journal of Medicine
https://read.qxmd.com/read/38532020/contemporary-pharmacological-treatment-and-management-of-heart-failure
#10
REVIEW
Biykem Bozkurt
The prevention and treatment strategies for heart failure (HF) have evolved in the past two decades. The stages of HF have been redefined, with recognition of the pre-HF state, which encompasses asymptomatic patients who have developed either structural or functional cardiac abnormalities or have elevated plasma levels of natriuretic peptides or cardiac troponin. The first-line treatment of patients with HF with reduced ejection fraction includes foundational therapies with angiotensin receptor-neprilysin inhibitors, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β-blockers, mineralocorticoid receptor antagonists, sodium-glucose cotransporter 2 (SGLT2) inhibitors and diuretics...
March 26, 2024: Nature Reviews. Cardiology
https://read.qxmd.com/read/38308229/the-effect-of-haloperidol-s-perioperative-application-on-postoperative-delirium-in-elderly-patients-a-systematic-review-and-meta-analysis
#11
JOURNAL ARTICLE
Meinv Liu, Jie Su, Bei Wang, Dongdong Yu, Jianli Li, Xinyu Cao
OBJECTIVES: To systematically review the evidence about the effect of haloperidol on postoperative delirium in elderly patients. METHODS: PubMed, Embase, the Cochrane Library and China National Knowledge Infrastructure were used to find concerned studies for meta-analysis. The main outcome was the incidence of postoperative delirium, and the secondary outcomes were side effects of haloperidol and the length of hospital stay. The meta-analyses were conducted using the Review Manager Version 5...
February 3, 2024: BMC Anesthesiology
https://read.qxmd.com/read/38521735/time-to-diagnosis-and-its-predictors-in-syndromes-associated-with-frontotemporal-lobar-degeneration
#12
JOURNAL ARTICLE
Ilenia Libri, Daniele Altomare, Valeria Bracca, Jasmine Rivolta, Valentina Cantoni, Irene Mattioli, Antonella Alberici, Barbara Borroni
OBJECTIVES: Frontotemporal Lobar Degeneration (FTLD) causes a heterogeneous group of neurodegenerative disorders with a wide range of clinical features. This might delay time to diagnosis. The aim of the present study is to establish time to diagnosis and its predictors in patients with FTLD-associated syndromes. DESIGN: Retrospective study. SETTING: Tertiary referral center. PARTICIPANTS: A total of 1029 patients with FTLD-associated syndromes (age: 68 [61-73] years, females: 46%) from 1999 to 2023 were included in the present study...
March 7, 2024: American Journal of Geriatric Psychiatry
https://read.qxmd.com/read/38521736/cognitive-and-hippocampal-changes-in-older-adults-with-subjective-cognitive-decline-after-acupuncture-intervention
#13
JOURNAL ARTICLE
Xu Wang, Hang Zhou, Chao-Qun Yan, Guang-Xia Shi, Ping Zhou, Jian-Wei Huo, Jing-Wen Yang, Ya-Nan Zhang, Lu Wang, Yan Cao, Cun-Zhi Liu
OBJECTIVE: Converging evidence indicates that subjective cognitive decline (SCD) could be an early indicator of dementia. The hippocampus is the earliest affected region during the progression of cognitive impairment. However, little is known about whether and how acupuncture change the hippocampal structure and function of SCD individuals. METHODS: Here, we used multi-modal MRI to reveal the mechanism of acupuncture in treating SCD. Seventy-two older participants were randomized into acupuncture or sham acupuncture group and treated for 12 weeks...
March 7, 2024: American Journal of Geriatric Psychiatry
https://read.qxmd.com/read/38320811/2023-eular-recommendations-on-imaging-in-diagnosis-and-management-of-crystal-induced-arthropathies-in-clinical-practice
#14
JOURNAL ARTICLE
Peter Mandl, Maria Antonietta D'Agostino, Victoria Navarro-Compán, Irina Geßl, Garifallia Sakellariou, Abhishek Abhishek, Fabio Becce, Nicola Dalbeth, Hang-Korng Ea, Emilio Filippucci, Hilde Berner Hammer, Annamaria Iagnocco, Annette de Thurah, Esperanza Naredo, Sebastien Ottaviani, Tristan Pascart, Fernando Pérez-Ruiz, Irene A Pitsillidou, Fabian Proft, Juergen Rech, Wolfgang A Schmidt, Luca Maria Sconfienza, Lene Terslev, Brigitte Wildner, Pascal Zufferey, Georgios Filippou
OBJECTIVE: To formulate evidence-based recommendations and overarching principles on the use of imaging in the clinical management of crystal-induced arthropathies (CiAs). METHODS: An international task force of 25 rheumatologists, radiologists, methodologists, healthcare professionals and patient research partners from 11 countries was formed according to the EULAR standard operating procedures. Fourteen key questions on the role of imaging in the most common forms of CiA were generated...
February 6, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38533613/effects-of-prognostic-communication-strategies-on-emotions-coping-and-appreciation-of-consultations-an-experimental-study-in-advanced-cancer
#15
JOURNAL ARTICLE
Naomi C A van der Velden, Ellen M A Smets, Liesbeth M van Vliet, Linda Brom, Hanneke W M van Laarhoven, Inge Henselmans
OBJECTIVES: We aimed to investigate effects of prognostic communication strategies on emotions, coping, and appreciation of consultations in advanced cancer. METHODS: For this experimental study, we created 8 videos of a scripted oncological consultation, only varying in prognostic communication strategies. Disease-naive individuals ( n = 1036) completed surveys before and after watching 1 video, while imagining being the depicted cancer patient. We investigated effects of the type of disclosure (prognostic disclosure vs...
March 27, 2024: Palliative & Supportive Care
https://read.qxmd.com/read/30039453/outpatient-comprehensive-geriatric-assessment-effects-on-frailty-and-mortality-in-old-people-with-multimorbidity-and-high-health-care-utilization
#16
RANDOMIZED CONTROLLED TRIAL
Amelie Lindh Mazya, Peter Garvin, Anne W Ekdahl
BACKGROUND: Multimorbidity and frailty are often associated and Comprehensive Geriatric Assessment (CGA) is considered the gold standard of care for these patients. AIMS: This study aimed to evaluate the effect of outpatient Comprehensive Geriatric Assessment (CGA) on frailty in community-dwelling older people with multimorbidity and high health care utilization. METHODS: The Ambulatory Geriatric Assessment-Frailty Intervention Trial (AGe-FIT) was a randomized controlled trial (intervention group, n = 208, control group n = 174) with a follow-up period of 24 months...
April 2019: Aging Clinical and Experimental Research
https://read.qxmd.com/read/31732374/concepts-in-practice-geriatric-emergency-departments
#17
JOURNAL ARTICLE
Lauren T Southerland, Alexander X Lo, Kevin Biese, Glenn Arendts, Jay Banerjee, Ula Hwang, Scott Dresden, Vivian Argento, Maura Kennedy, Christina L Shenvi, Christopher R Carpenter
In 2018, the American College of Emergency Physicians (ACEP) began accrediting facilities as "geriatric emergency departments" (EDs) according to adherence to the multiorganizational guidelines published in 2014. The guidelines were developed to help every ED improve its care of older adults. The geriatric ED guideline recommendations span the care continuum from out-of-hospital care, ED staffing, protocols, infrastructure, and transitions to outpatient care. Hospitals interested in making their EDs more geriatric friendly thus face the challenge of adopting, adapting, and implementing extensive guideline recommendations in a cost-effective manner and within the capabilities of their facilities and staff...
February 2020: Annals of Emergency Medicine
https://read.qxmd.com/read/38423660/cannabinoids-for-cancer-related-pain-management-an-update-on-therapeutic-applications-and-future-perspectives
#18
REVIEW
Sabrina Bimonte, Davide Nocerino, Daniela Schiavo, Marco Crisci, Marco Cascella, Arturo Cuomo
Pain is a debilitating phenomenon that dramatically impairs the quality of life of patients. Many chronic conditions, including cancer, are associated with chronic pain. Despite pharmacological efforts that have been conducted, many patients suffering from cancer pain remain without treatment. To date, opioids are considered the preferred therapeutic choice for cancer-related pain management. Unfortunately, opioid treatment causes side effects and inefficiently relieves patients from pain, therefore alternative therapies have been considered, including Cannabis Sativa and cannabinoids...
March 2024: Anticancer Research
https://read.qxmd.com/read/28747535/palliative-care-in-end-stage-valvular-heart-disease
#19
REVIEW
Jill M Steiner, Stephanie Cooper, James N Kirkpatrick
Valvular heart disease (VHD), particularly aortic valve disease, is prevalent with increasing incidence. When surgery is not possible, or when risks outweigh benefits, percutaneous treatment options may offer effective alternatives. However, procedures may not always go as planned, and frail patients or those whose symptoms are caused by other comorbidities may not benefit from valve intervention at all. Significant effort should be made to assess frailty, comorbidities and patient goals prior to intervention...
August 2017: Heart
https://read.qxmd.com/read/38396839/current-understanding-of-immune-thrombocytopenia-a-review-of-pathogenesis-and-treatment-options
#20
REVIEW
Alina Mititelu, Minodora-Cezarina Onisâi, Adrian Roșca, Ana Maria Vlădăreanu
The management of immune thrombocytopenia (ITP) and the prediction of patient response to therapy still represent a significant and constant challenge in hematology. ITP is a heterogeneous disease with an unpredictable evolution. Although the pathogenesis of ITP is currently better known and its etiology has been extensively studied, up to 75% of adult patients with ITP may develop chronicity, which represents a significant burden on patients' quality of life. A major risk of ITP is bleeding, but knowledge on the exact relationship between the degree of thrombocytopenia and bleeding symptoms, especially at a lower platelet count, is lacking...
February 10, 2024: International Journal of Molecular Sciences
label_collection
label_collection
1048
1
2
2024-03-26 00:25:03
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.